Predictive Oncology (POAI)
(Delayed Data from NSDQ)
$1.76 USD
+0.02 (1.15%)
Updated May 9, 2024 04:00 PM ET
After-Market: $1.73 -0.03 (-1.70%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Predictive Oncology Inc. [POAI]
Reports for Purchase
Showing records 1 - 9 ( 9 total )
Company: Predictive Oncology Inc.
Industry: Medical - Drugs
Company: Predictive Oncology Inc.
Industry: Medical - Drugs
Company: Predictive Oncology Inc.
Industry: Medical - Drugs
Revenue Growth and Gross Margin Improvement Continue to Impress; Reiterate Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Predictive Oncology Inc.
Industry: Medical - Drugs
Acquisition advances patient centric therapies - Reiterate Buy and $5 PT
Provider: Litchfield Hills Research, LLC
Analyst: O'NEILL T
Company: Predictive Oncology Inc.
Industry: Medical - Drugs
Update for 3Q21 results - Reiterate Buy and $5 PT
Provider: Litchfield Hills Research, LLC
Analyst: O'NEILL T
Company: Predictive Oncology Inc.
Industry: Medical - Drugs
AI Platform Makes Important Early Steps; Reiterate Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Predictive Oncology Inc.
Industry: Medical - Drugs
Company: Predictive Oncology Inc.
Industry: Medical - Drugs
Capitalization Present a Promising Opportunity
Provider: Quantum Research Group, LLC
Analyst: Research Department
Company: Predictive Oncology Inc.
Industry: Medical - Drugs
Putting PeDAL to the Drug Discovery Mettle; Initiating Coverage With a Buy Rating and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
|